This article is a US Government work and, as such, is in the public domain in the United States of America.
Article first published online: 15 SEP 2008
Copyright © 2008 Wiley-Liss, Inc.
American Journal of Medical Genetics Part A
Volume 146A, Issue 20, pages 2701–2705, 15 October 2008
How to Cite
Petersen, E. E., Mitchell, A. A., Carey, J. C., Werler, M. M., Louik, C. and Rasmussen, S. A. (2008), Maternal exposure to statins and risk for birth defects: A case-series approach. Am. J. Med. Genet., 146A: 2701–2705. doi: 10.1002/ajmg.a.32493
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Following completion of this manuscript, Dr. Mitchell was approached by Merck and served as a consultant regarding an assessment of statin safety in pregnancy.
How to cite this article: Petersen EE, Mitchell AA, Carey JC, Werler MM, Louik C, Rasmussen SA, the National Birth Defects Prevention Study. 2008. Maternal exposure to statins and risk for birth defects: A case-series approach. Am J Med Genet Part A 146A:2701–2705.
- Issue published online: 24 SEP 2008
- Article first published online: 15 SEP 2008
- Manuscript Accepted: 24 JUN 2008
- Manuscript Received: 31 AUG 2007
- National Institute of Child Health and Human Development. Grant Number: HD27697
- National Heart, Lung, and Blood Institute. Grant Number: HL 50763
- Massachusetts Center for Birth Defects Research and Prevention, Massachusetts Department of Public Health
- Aventis, Inc.
- Sanofi Pasteur, Inc.
- CDC Foundation